Latest news with #growthinvesting
Bloomberg
6 days ago
- Business
- Bloomberg
TPG Raises $4.8 Billion for Growth Fund, Beating Initial Target
TPG Inc. gathered $4.8 billion for the latest iteration of a fund that bets on rapidly growing earlier-stage companies. The private equity firm said it exceeded its initial $4 billion target for TPG Growth VI, adding new investors from the Middle East, Asia and Latin America. TPG took about two years to raise the fund, part of a strategy dating to 2007 that focuses on investments in software and enterprise technology, internet, digital media and communications, health care and business services.
Yahoo
04-08-2025
- Business
- Yahoo
High Growth Tech Stocks To Watch In Europe July 2025
As Europe navigates a landscape marked by tentative optimism surrounding an EU-U.S. trade deal and the European Central Bank's steady interest rates, the pan-European STOXX Europe 600 Index has seen modest gains, reflecting a cautious yet resilient market sentiment. In this environment, high-growth tech stocks in Europe can be particularly appealing to investors looking for innovation-driven opportunities that align with broader economic trends and technological advancements. Top 10 High Growth Tech Companies In Europe Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 28.42% 47.04% ★★★★★★ Shoper 14.28% 23.79% ★★★★★☆ KebNi 20.56% 94.46% ★★★★★★ Bonesupport Holding 23.98% 62.26% ★★★★★★ Lipigon Pharmaceuticals 104.89% 93.94% ★★★★★☆ Yubico 16.27% 23.90% ★★★★★☆ ContextVision 5.83% 39.78% ★★★★★☆ Aelis Farma 79.30% 106.93% ★★★★★☆ SyntheticMR 18.81% 47.40% ★★★★★☆ CD Projekt 33.57% 40.19% ★★★★★☆ Click here to see the full list of 52 stocks from our European High Growth Tech and AI Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Pharming Group Simply Wall St Growth Rating: ★★★★☆☆ Overview: Pharming Group N.V. is a biopharmaceutical company that focuses on developing and commercializing protein replacement therapies and precision medicines for rare diseases across the United States, Europe, and other international markets, with a market cap of €596.08 million. Operations: Pharming Group generates revenue primarily through its Recombinant Human C1 Esterase Inhibitor business, which accounts for $320.71 million. The company's focus is on providing treatments for rare diseases in various international markets. Pharming Group N.V. is navigating a complex landscape with an 8.3% expected annual revenue growth, which, although modest compared to some high-growth sectors, outpaces the Dutch market's 7.3%. The company's commitment to innovation is underscored by its significant R&D efforts aimed at tackling rare diseases like APDS; this focus not only differentiates it within the biotech industry but also enhances its potential in a niche market. Recent announcements include the hosting of a webcast to discuss groundbreaking findings in immune disorders and an upgrade in revenue guidance for 2025 to USD 325-340 million, reflecting positive business momentum. These developments suggest Pharming is strategically poised to leverage scientific advances into commercial success, despite current unprofitability and market challenges. Dive into the specifics of Pharming Group here with our thorough health report. Assess Pharming Group's past performance with our detailed historical performance reports. BioInvent International Simply Wall St Growth Rating: ★★★★★☆ Overview: BioInvent International AB (publ) is a clinical-stage company focused on discovering and developing immuno-modulatory antibodies for cancer treatment, with a market cap of approximately SEK2.64 billion. Operations: The company generates revenue primarily from developing antibody-based drugs, amounting to SEK60.80 million. BioInvent International is making significant strides in the biotech sector, particularly with its innovative BI-1808 treatment for cutaneous T-cell lymphoma (CTCL), demonstrating a 100% disease control rate in recent trials. This promising performance is underpinned by a robust annual revenue growth forecast of 76.6% and an earnings growth projection of 91.77%. With R&D expenses aligned to propel future innovations, BioInvent not only surpasses the Swedish market's growth rate of 5.2% but also outpaces biotech industry norms, positioning it well for upcoming profitability within three years. Click here and access our complete health analysis report to understand the dynamics of BioInvent International. Gain insights into BioInvent International's past trends and performance with our Past report. Bonesupport Holding Simply Wall St Growth Rating: ★★★★★★ Overview: Bonesupport Holding AB (publ) is an orthobiologics company that specializes in developing and selling injectable bio-ceramic bone graft substitutes across Europe, North America, and other international markets, with a market cap of SEK21.76 billion. Operations: Bonesupport Holding AB generates revenue primarily from its pharmaceuticals segment, amounting to SEK1.06 billion. The company focuses on the development and sale of injectable bio-ceramic bone graft substitutes across various regions, including Europe and North America. Bonesupport Holding's recent financial performance underscores its potential within the European tech landscape, with a notable increase in Q2 sales to SEK 284.43 million from SEK 219.8 million the previous year, and net income more than doubling to SEK 53.07 million. This growth trajectory is complemented by an ambitious R&D strategy, critical for maintaining technological leadership and competitiveness. The company's robust revenue growth rate of 24% annually outpaces the broader Swedish market's growth of 5.2%, positioning it well for sustained advancements in its sector. Additionally, with earnings expected to surge by 62.3% annually, Bonesupport is poised to capitalize on expanding market opportunities while enhancing shareholder value through strategic reinvestments in innovation and market expansion initiatives. Take a closer look at Bonesupport Holding's potential here in our health report. Review our historical performance report to gain insights into Bonesupport Holding's's past performance. Seize The Opportunity Dive into all 52 of the European High Growth Tech and AI Stocks we have identified here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Ready For A Different Approach? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTAM:PHARM OM:BINV and OM:BONEX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
04-08-2025
- Business
- Yahoo
High Growth Tech Stocks In Europe To Watch July 2025
The European market has shown tentative optimism as the pan-European STOXX Europe 600 Index rose by 0.54%, buoyed by hopes of a potential EU-U.S. trade deal and steady interest rates from the European Central Bank, despite lingering uncertainties in global trade dynamics. In this environment, high-growth tech stocks in Europe become particularly intriguing to investors seeking opportunities that align with current market conditions, where resilience and adaptability to geopolitical changes are key factors for success. Top 10 High Growth Tech Companies In Europe Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 28.42% 47.04% ★★★★★★ KebNi 20.56% 65.02% ★★★★★★ Comet Holding 12.58% 32.19% ★★★★★☆ Lipigon Pharmaceuticals 104.89% 93.94% ★★★★★☆ Yubico 16.27% 23.90% ★★★★★☆ Bonesupport Holding 23.98% 62.26% ★★★★★★ ContextVision 5.83% 39.78% ★★★★★☆ SyntheticMR 18.81% 47.40% ★★★★★☆ Aelis Farma 79.30% 106.93% ★★★★★☆ CD Projekt 33.57% 40.19% ★★★★★☆ Click here to see the full list of 51 stocks from our European High Growth Tech and AI Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Pexip Holding Simply Wall St Growth Rating: ★★★★☆☆ Overview: Pexip Holding ASA is a video technology company that offers a comprehensive video conferencing platform and digital infrastructure across multiple regions including the Americas, Europe, the Middle East, Africa, and the Asia Pacific with a market capitalization of NOK6.25 billion. Operations: Pexip generates revenue primarily through the sale of collaboration services, amounting to NOK1.17 billion. Pexip Holding's recent strategic moves, including a share repurchase program and robust quarterly earnings growth, underscore its upward trajectory in the high-tech sector. With a revenue increase to NOK 347.95 million from NOK 291.98 million year-over-year and net income rising to NOK 66.37 million from NOK 45.41 million, the company is demonstrating solid financial health. Notably, Pexip's commitment to innovation is evident as it earmarks substantial funds (NOK 100 million) for share-based compensation plans through its buyback strategy, aligning interests with long-term shareholder value and employee incentives. This approach not only enhances capital efficiency but also positions Pexip favorably within Europe's competitive tech landscape as it continues to outpace average market growth with a projected annual revenue increase of 9.4% and earnings growth of 25.5%. Click here and access our complete health analysis report to understand the dynamics of Pexip Holding. Evaluate Pexip Holding's historical performance by accessing our past performance report. CD Projekt Simply Wall St Growth Rating: ★★★★★☆ Overview: CD Projekt S.A. is a Polish company that, along with its subsidiaries, focuses on developing, publishing, and digitally distributing video games for personal computers and consoles, with a market capitalization of PLN25.19 billion. Operations: CD Projekt, along with its subsidiaries, generates revenue primarily through CD PROJEKT RED, contributing PLN795.50 million, and adding PLN203.79 million. The company focuses on video game development and distribution for PCs and consoles in Poland. CD Projekt, navigating through a challenging landscape with a slight dip in quarterly revenue to PLN 226.31 million from PLN 226.79 million, still managed to maintain robust projections with expected annual revenue growth at an impressive 33.6%. Despite a recent decline in net income from PLN 100.06 million to PLN 86 million, the company is poised for significant earnings expansion, forecasted at an annual rate of 40.2%. This growth trajectory is bolstered by strategic R&D investments aimed at fostering innovation and securing its competitive edge in the dynamic gaming industry. These financial and strategic maneuvers highlight CD Projekt's resilience and adaptability within Europe's tech sector, underscoring its potential amidst evolving market demands and consumer preferences. Click here to discover the nuances of CD Projekt with our detailed analytical health report. Understand CD Projekt's track record by examining our Past report. Shoper Simply Wall St Growth Rating: ★★★★☆☆ Overview: Shoper S.A. is a Polish company offering Software as a Service solutions for e-commerce, with a market capitalization of PLN1.35 billion. Operations: Shoper S.A. generates revenue primarily through its Solutions segment, contributing PLN157.26 million, and Subscriptions, adding PLN43.08 million. Shoper S.A. has demonstrated a robust growth trajectory, with earnings surging by 37.8% over the past year, outpacing the software industry's average of 20.9%. This growth is underpinned by a significant annual revenue increase of 14.3%, which exceeds the broader Polish market's growth rate of 4.5%. Notably, Shoper's strategic focus on R&D has been crucial in maintaining its competitive edge and fostering innovation within the tech landscape. The firm's recent financial results reflect this momentum, with first-quarter revenue climbing to PLN 51.73 million from PLN 44.19 million year-over-year and net income rising to PLN 9.84 million from PLN 7.76 million in the same period last year, signaling strong operational performance and potential for sustained growth. Unlock comprehensive insights into our analysis of Shoper stock in this health report. Review our historical performance report to gain insights into Shoper's's past performance. Make It Happen Access the full spectrum of 51 European High Growth Tech and AI Stocks by clicking on this link. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OB:PEXIP WSE:CDR and WSE:SHO. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
31-07-2025
- Business
- Yahoo
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, try the growth at a reasonable price or GARP strategy helps investors gain exposure to undervalued stocks with impressive prospects. Unlike a blend strategy, a portfolio that uses GARP investing is expected to include stocks that offer the best of value and growth investing. GE Aerospace GE, Autodesk ADSK, Adobe ADBE and Sprouts Farmers Market SFM are some GARP stocks that hold promise. GARP Metrics: Mix of Growth & Value Metrics The GARP strategy seeks to offer an ideal investment by utilizing the best features of value and growth investing. Investors adopting the GARP approach prefer buying stocks priced below the market or any reasonable target determined by fundamental analysis. These stocks also have solid prospects in terms of cash flow, revenues, earnings per share (EPS) and so MetricsA strong earnings growth history and impressive earnings prospects are the main concepts that GARP investors borrow from the growth investing strategy. However, instead of super-normal growth rates, pursuing stocks with a more stable and reasonable growth rate is a tactic of GARP investors. Hence, growth rates between 10% and 20% are considered ideal under the GARP metric that growth and GARP investors consider is return on equity (ROE). GARP investors look for a strong and higher ROE than the industry average to identify superior stocks. Stocks with positive cash flows find precedence under the GARP MetricsGARP investing prioritizes the popular value metrics — the price-to-earnings (P/E) and price-to-book (P/B) ratios. Though this investing style picks stocks with higher P/E ratios than value investors, it avoids companies with extremely high P/E the GARP principle, we ran a screen to identify stocks that should offer solid returns in the near term. Screening Parameters Along with the criteria discussed in the above section, we have considered a Zacks Rank #1 (Strong Buy) or 2 (Buy). (Strong EPS growth history and prospects ensure improving business.)ROE (over the past 12 months) greater than the industry average (Higher ROE than the industry average indicates superior stocks.)P/E and P/B ratios less than the M-industry average (P/E and P/B ratios less than that of the industry indicate that the stocks are undervalued.)Here are four stocks from the five that made it through the screening process:GE Aerospace is a leading designer, developer and producer of jet engines, components and integrated systems for military, commercial and business aircraft. The company is well-known for its aero-derivative gas turbines for marine Aerospace has been witnessing strength in its businesses, driven by robust demand for commercial engines, propulsion and additive technologies. Rising U.S. & international defense budgets, geopolitical tensions, positive airline & airframer dynamics and robust demand for commercial air travel augur well for the company. Its portfolio-reshaping actions are likely to unlock value for its shareholders. For 2025, GE Aerospace expects organic revenues to grow in the low-double-digit range from the year-ago Zacks Rank #1 stock has surged 62.1% in the year-to-date period. It has a trailing four-quarter earnings surprise of 16.07%, on average. The Zacks Consensus Estimate for GE's 2025 earnings has moved north by 6.5% to $5.87 per share over the past 30 days. You can see the complete list of today's Zacks #1 Rank stocks develops model-based design, engineering and documentation software. The company serves customers in architecture, engineering and construction; product design and manufacturing; and digital media and entertainment performance is gaining from new business growth, steady subscription renewal rates and strong competitive performance. Higher demand for its cloud-based products, mobile solutions and design suites is expected to drive the company's revenues over the long haul. The rapid adoption of BIM 360 products and the success of the maintenance of the subscription program bode well for the growth of the company. Autodesk's top-line growth is expected to remain strong, thanks to the demand for its AEC, AutoCAD and manufacturing product Zacks Rank #2 stock has returned 3.7% in the year-to-date period. It has a trailing four-quarter earnings surprise of 6.22%, on average. The Zacks Consensus Estimate for ADSK's fiscal 2026 earnings has moved north by 0.1% to $9.64 per share over the past 30 tools, like Acrobat AI Assistant and Adobe Express, are attracting business professionals and creators. Acrobat AI Assistant uses conversational interfaces to make it easier for users to read digital documents and gain insights within a short timeframe. Adobe Express is using AI to enable consumers to quickly design and publish content through conversational AI in an easy-to-use, all-in-one application. Adobe's monthly active users across these categories surpassed more than 700 million users at the end of the second quarter of fiscal 2025. The Firefly App is attracting users for AI-powered content ideation, creation and production, and its support for third-party models, including from Alphabet division Google's Imagen and Veo, Microsoft-backed OpenAI's image generation and Black Forest Labs' Flux, is a key catalyst. Adobe Firefly App availability on mobile is expected to further boost its Zacks Rank #2 stock has declined 16.6% in the year-to-date period. It has a trailing four-quarter earnings surprise of 2.53%, on average. The Zacks Consensus Estimate for ADBE's fiscal 2025 earnings has moved north by 0.1% to $20.63 per share over the past 30 Farmers Market's commitment to providing fresh produce and health-oriented products aligns with increasing consumer demand for healthier food options. The overall market for natural and organic food at home, which SFM targets, is estimated to be around $290 billion within the total $1.6 trillion spent on food at home. Its private-label products continue to gain traction, accounting for 24% of total sales, with 300 new items launched last year, fostering customer loyalty. Sprouts Farmers plans to open at least 35 new stores in 2025, targeting approximately 10% unit growth, supported by a robust pipeline of 120 approved sites and more than 85 signed leases. Embracing a multi-channel approach, Sprouts Farmers continues to adapt to shifting consumer shopping habits. Significant investments in digital infrastructure, online ordering and delivery services have enhanced customer Zacks Rank #2 stock has returned 23.5% in the year-to-date period. It has a trailing four-quarter earnings surprise of 16.5%, on average. The Zacks Consensus Estimate for SFM's 2025 earnings has remained steady at $5.08 per share over the past 30 days. You can get the remaining stock on this list by signing up now for a 2-week free trial to the Research Wizard stock picking and backtesting software. You can also create your own strategies and test them first before making Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in and see what gems come here to sign up for a free trial of the Research Wizard Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this Performance information for Zacks' portfolios and strategies are available at: Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GE Aerospace (GE) : Free Stock Analysis Report Autodesk, Inc. (ADSK) : Free Stock Analysis Report Adobe Inc. (ADBE) : Free Stock Analysis Report Sprouts Farmers Market, Inc. (SFM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
30-07-2025
- Automotive
- Yahoo
Can These 2 Monster Growth Stocks Hit New Highs? Here's What Oppenheimer Thinks
Every investor aims to build a portfolio that grows steadily and delivers meaningful returns. Growth investing remains a time-tested strategy for achieving just that. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The secret to success starts with spotting companies that have solid fundamentals, innovative products, or a clever twist on a proven formula. These are the kinds of businesses that tend to capture attention – and fuel long-term gains. Recent share price surges may draw attention, but they shouldn't be viewed in isolation. While impressive growth over the past year can be encouraging, it's not a guarantee of what lies ahead. The well-worn adage still applies: past performance doesn't ensure future results. However, when a stock has more than doubled over 12 months and is backed by a strong business case, it's worth serious consideration, especially if it aligns with the traits that typically underpin lasting growth. Against this backdrop, we've used the TipRanks database to zero in on two monster growth stocks that have recently caught the bullish attention of Oppenheimer analysts. Let's take a closer look at what makes these picks worth watching. Carvana Company (CVNA) We'll start with Carvana, a company that has been changing the face of the used car market. Carvana, based in Arizona, was founded and launched in 2012; the company makes available an online marketplace for used cars. Customers can browse the site, searching for the correct car using a variety of parameters – and then can compare prices. Carvana's online shopping platform is available on PCs, but can also be accessed as a mobile app, allowing customers to take their search results with them when they go to look at vehicles. In a unique feature, Carvana maintains a network of 'car vending machines' around the US, where customers can go to visually inspect the cars they find through the online platform – this is a sound insight from the company, recognizing that while anything can be found or bought online, some products need to be seen by the customer before the final purchase. Carvana's vending machines are multi-story automated parking structures, with windowed parking slots, allowing customers to view prospective purchases and even to physically inspect the vehicles. In addition to its vending machines, and serving areas that are both near the machines or far from them, Carvana also offers purchase delivery services. Once a customer has purchased a vehicle, the company will deliver it to the customer's home – and in several areas, that service is available as same-day delivery. We should note that this past May, Carvana expanded its same-day delivery, adding Denver, Colorado to the list. Carvana's services have proven popular, as a platform for both buying and selling used vehicles. Over the past year, the company has seen its stock price increase by an impressive 163%. The company has impressed investors in several ways: with its successful business model; its plans for expansion; and its recent growth in both revenue and earnings. For its last reported quarter, 1Q25, Carvana reported total revenues of $4.23 billion – a record figure that was up 38% year-over-year, and beat the forecast by $230 million. The company's revenue was based on retail sales of 133,898 units, for a 46% year-over-year jump. At the bottom line, Carvana realized a record-level net income of $373 million. We'll see Carvana's Q2 results on July 30, after the markets close. Oppenheimer analyst Brian Nagel is impressed by Carvana, particularly by the company's proven ability to disrupt the used car market and to carve out a unique and profitable niche therein, with potential for expansion. 'CVNA represents a unique, digitally-driven disruptor, within the expansive and inefficient domestic used car marketplace. Following significant fundamental and financial repositioning, the CVNA business model is now 'humming,' generating meaningful cash, scaling, and capitalizing well upon improving, underlying demand trends, within the space. We have undertaken a refreshed deep-dive analysis of Carvana and conclude that while shares have rebounded to all-time highs that investors still under-appreciate near- and longer-term growth and profit potential, for the company. CVNA and the used car space are situated well to capitalize upon ongoing trade disruptions as tariffs likely drive prices for new autos higher,' Nagel explained. These comments support Nagel's recent upgrade from Perform (i.e., Neutral) to Outperform (i.e., Buy), with a $450 price target that suggests a one-year upside potential of 34%. (To watch Nagel's track record, click here) Carvana's Moderate Buy consensus rating is based on 19 recent analyst recommendations, that include 13 to Buy against 6 to Hold. The shares are priced at $336.33 and their $359.06 average price target implies a gain for the coming year of 7%. (See CVNA stock forecast) Spotify Technology (SPOT) From cars, we'll switch to music, and look at Spotify. This Swedish-based company was founded in 2006, and over the past two decades it has built itself into a leader in the online on-demand music streaming segment. Today, Spotify boasts a market cap of $141 billion, reflecting both its early entry into the profitable music subscription niche and the popularity of online music streaming. Spotify offers its service through the subscription model, with paying users able to choose from an extensive library of audio files and sources, including more than 100 million songs, 7 million podcasts, and an expanding audiobook library that currently has 350,000 titles. The company boasts that it has over 670 million users worldwide, a total that includes some 268 million paying subscribers. An audio library that size presents difficulties, however. Listeners can't begin to hope to browse all of the titles, and fans may have difficulty finding their favorite songs or podcasts. Spotify uses AI technology to help meet this challenge, putting the tech to work building playlists or offering suggestions based on users' previous selections. For the more old-school users, the site also offers the more traditional search options of a search bar and categorized audio files. The company will report its 2Q25 results today (July 29) before the opening bell, against a backdrop of ample share gains. The stock is up by 116.5% in the last 12 months. According to Bloomberg consensus estimates, Wall Street is expecting revenue of €4.27 billion, up from €3.81 billion in 2Q24, and adj. EPS of €1.97, compared with €1.33 in the same period last year. Oppenheimer analyst Jason Helfstein sees plenty of reasons to expect continued gains here. 'We believe that SPOT will benefit from the secular tailwind of growing digital audio streaming adoption and that the company's subscription economics are better than most believe,' Helfstein opined. 'We model 1) the largest MAU runway in Internet, 2) free tier monetization (either ads or ad-supported monthly fee), 3) conversion benefits from App Store changes, 4) Superfan tier, 5) continued GM leverage, and 6) FCF generation/share repurchases. Forecasting 16% revenue CAGR 2024-2030 based on a 9% subscriber CAGR and 21% ARPU CAGR driven primarily by ad monetization. SPOT meaningfully undermonetizes ad tier, with visibility to ~3x ad ARPU over time on podcasts and ad tools; if this fails, SPOT could establish a very small monthly fee for its lowest tier.' Quantifying his stance, the analyst recently upgraded SPOT shares from Perform (i.e., Neutral) to Outperform (i.e., Buy), pairing the new rating with an $800 price target – implying the stock could gain 14% over the coming year. (To watch Helfstein's track record, click here) Spotify shares have earned a Moderate Buy consensus rating from the Street's experts, based on 26 recent reviews that feature a breakdown of 19 Buys, 6 Holds, and 1 Sell. The stock has a current trading price of $700.98 and its $776.48 average target price implies that it has an 11% upside on the way by this time next year. (See SPOT stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
